Anaphylaxis warning for cough medicine
The TGA has issued an anaphylaxis warning about Bromhexine-containing cough and cold medicines.
The announcement follows confirmation by Europe’s Pharmacovigilance Risk Assessment Committee of severe allergic reactions associated with bromhexine- and ambroxol-containing medicines.
The committee also identified a small risk of severe cutaneous adverse reactions (SCARs). SCARs include erythema multiforme, Stevens-Johnson syndrome and acute generalised